Washington learned many lessons during the pandemic, though not all of them appear to have taken hold. One of the clearest is that federal health agencies can move money very quickly in an emergency, but they are far less reliable at ensuring that taxpayer dollars are spent wisely once the urgency of the moment takes over.
That matters because the sums involved were enormous. During the COVID-19 response, agencies including the Department of Health and Human Services and its subcomponents moved rapidly to acquire personal protective equipment, testing supplies, vaccines, therapeutics, logistics support, and a range of contractor services. Some of that speed was necessary. A government that cannot act in a genuine public health emergency is failing at a basic duty. But a government that spends in haste and audits as an afterthought creates a different kind of failure, one that taxpayers eventually finance in full.
Inspectors general, the Government Accountability Office, and congressional investigators have spent years documenting the vulnerabilities that emergency spending exposed: weak internal controls, insufficient documentation, rushed awards to vendors with limited performance histories, poor inventory tracking, and inconsistent oversight of whether contractors actually delivered what they promised. Add relaxed procedures and compressed timelines, and fraudsters naturally began to circle.
This was not merely bad luck. It was the predictable result of a contracting culture that too often treats oversight as a bureaucratic accessory rather than a core function of public stewardship.
The problem was bigger than a few bad actors
It is tempting to tell this story as one of isolated scams. Certainly there were fraudulent schemes, sham entities, and opportunists who used a national emergency as a business model. But the larger problem was structural. When agencies are rewarded primarily for obligating funds quickly, they will do exactly that. When contracting officers are overloaded, documentation standards loosen, and agency leaders signal that speed is the overriding priority, the system begins to tolerate risks that would never pass muster in ordinary times.
Federal health agencies also faced a challenge familiar across government: they lacked complete, real-time visibility into supply chains, contractor performance, and inventory management. In some cases, agencies acquired goods that arrived late, proved unnecessary, or could not be tracked efficiently once delivered. In other cases, the government paid premium prices in chaotic markets without building adequate safeguards into the contracts themselves.
Again, some of this was unavoidable. A pandemic is not a routine acquisition environment. But too much of the waste reflected weaknesses that long predated COVID-19: fragmented procurement systems, uneven workforce training, duplication across programs, and a chronic tendency to postpone hard reforms until after the emergency has passed and public attention has moved on.
What reform should look like
If Congress and the executive branch are serious about reforming government contracting, especially at federal health agencies, the goal should be straightforward: preserve emergency flexibility while rebuilding accountability. That requires more than speeches about lessons learned. It requires changes in process, staffing, and law.
Several reforms stand out.
- Strengthen pre-award vetting for emergency vendors. Agencies should maintain updated lists of prequalified suppliers for critical medical goods and services before the next crisis hits. Vetting in advance is far better than improvising under pressure.
- Require clearer documentation for sole-source and limited-competition awards. Emergency exceptions are sometimes justified, but they should trigger heightened review after the fact, not permanent opacity.
- Improve inventory and delivery tracking. If an agency cannot reliably track what it bought, where it went, and whether it was usable, it is not managing procurement; it is simply moving money.
- Expand the acquisition workforce. Contracting officers and oversight staff cannot perform miracles while buried under impossible caseloads. Competence is a capacity issue as much as a procedural one.
- Use data analytics aggressively. Payment anomalies, duplicate invoices, suspicious vendor patterns, and performance failures are easier to detect when systems can communicate with one another in real time.
- Enforce clawbacks and suspension tools. Contractors that defraud the government, or materially fail to perform, should not simply disappear and reappear under a new name for the next emergency.
None of this is glamorous. Procurement reform rarely is. But effective government often depends less on lofty rhetoric than on whether somebody checked the invoice, verified the shipment, and asked why the same item was purchased three times through three different channels.
Congress should focus on oversight, not theater
There is also an important legislative lesson here. Congressional oversight works best when it is disciplined, document-driven, and patient enough to follow the money through the bureaucracy. Too often, hearings on pandemic waste veer into familiar partisan performance. That may generate a sharp exchange for social media, but it does not produce durable reform.
A more serious Congress would press federal health agencies on contract closeouts, vendor accountability, stockpile management, and interagency coordination. It would ask how emergency acquisition authorities were used, where internal controls broke down, and which recommendations from watchdog reports remain unimplemented. It would also revisit whether agencies have too many overlapping procurement channels with too little centralized visibility.
That kind of oversight is not anti-government. It is the plain work of constitutional government. Appropriations without supervision are an engraved invitation to waste.
The conservative case for competent administration
Conservatives should be especially clear on this point. Skepticism of federal bureaucracy does not require indifference to its performance. In fact, the opposite is true. If government is going to exercise extraordinary powers and spend extraordinary sums in an emergency, it owes the public extraordinary discipline in how it does so.
There is a bad habit in Washington of treating administrative competence as a secondary concern, as though efficiency and accountability were merely managerial details beneath the dignity of larger ideological disputes. But for ordinary Americans, these details are the thing itself. Waste in a health contract is not abstract. It means borrowed money, weaker public confidence, and fewer resources available when the next real emergency arrives.
It also strengthens the public suspicion that federal agencies operate in a world insulated from consequence. That is a dangerous perception in a self-governing republic. Trust, once spent, is harder to replenish than any appropriated fund.
Preparation beats improvisation
The central lesson from pandemic-era fraud and waste at federal health agencies is not that government should freeze in a crisis. It is that the government must prepare in advance so that speed and accountability are not treated as mutually exclusive. Emergency procurement will always involve risk. The choice is whether that risk is managed by serious institutions with clear rules, or simply absorbed by taxpayers after the fact.
Washington had ample warning before COVID-19 that its contracting systems were vulnerable under stress. It now has ample evidence of what happens when those vulnerabilities are ignored. The question is whether policymakers will act while the lesson is still visible.
If they do not, the next emergency will produce the same familiar cycle: urgent spending, weak controls, delayed oversight, and solemn promises afterward that reform is finally coming. By now, taxpayers are entitled to ask for something better than another post-crisis vow. They are entitled to a government that can act quickly without forgetting that the money is theirs.
